Gene therapy trial aims to boost HIV fight in lymphoma patients
NCT ID NCT02337985
First seen Nov 10, 2025 · Last updated May 16, 2026 · Updated 23 times
Summary
This early-stage trial tests whether adding gene therapy to standard chemotherapy can help people with AIDS-related lymphoma fight both cancer and HIV. Ten participants receive chemotherapy followed by an infusion of their own blood stem cells modified with anti-HIV genes. The main goal is to check safety and see if the gene-modified cells survive in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NCI Lymphoid Malignancies Branch
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.